The global preimplantation genetic testing market was estimated to be valued at USD 802.2 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 10.3% from 2024 to 2030. The increasing prevalence of single-gene, mitochondrial, and other genetic disorders is expected to drive the demand for preimplantation diagnosis and screening processes in the coming...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian